Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage

[1]  R. Shigemoto,et al.  mGluR7-like receptor and GABAB receptor activation enhance neurotoxic effects of N-methyl-d-aspartate in cultured mouse striatal GABAergic neurones , 1999, Neuropharmacology.

[2]  D. Laurie,et al.  (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. , 1999, The Journal of pharmacology and experimental therapeutics.

[3]  F. Nicoletti,et al.  Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors , 1999, Neuropharmacology.

[4]  M. O'Neill,et al.  Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia , 1998, Neuroreport.

[5]  M. G. Lacey,et al.  Metabotropic glutamate receptors depress glutamate‐mediated synaptic input to rat midbrain dopamine neurones in vitro , 1998, British journal of pharmacology.

[6]  G. Siggins,et al.  Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. , 1997, Journal of neurophysiology.

[7]  D. Jane,et al.  Anti-epileptogenic and anticonvulsant activity of l-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist , 1997, Brain Research.

[8]  P. Roberts,et al.  Inhibition of AMPA Receptor-stimulated 57Co2+ Influx by d- and l-2-Amino-4-phosphonobutanoic Acid (d- and l-AP4) and l-Serine-O-phosphate (l-SOP) in Cultured Cerebellar Granule Cells , 1997, Neuropharmacology.

[9]  M. Moskowitz,et al.  Reduced Brain Edema and Infarction Volume in Mice Lacking the Neuronal Isoform of Nitric Oxide Synthase after Transient MCA Occlusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  S. Urwyler,et al.  Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-Methyl-D-aspartate receptor antagonists—II. Pharmacological characterization in vivo , 1996, Neuropharmacology.

[11]  M. Miras-Portugal,et al.  A Decrease in [Ca2+]c but not in cAMP Mediates L‐AP4 Inhibition of Glutamate Release: PKC‐mediated Suppression of this Inhibitory Pathway , 1996, The European journal of neuroscience.

[12]  P. Conn,et al.  Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  Katsuaki Suzuki,et al.  Anticonvulsant action of metabotropic glutamate receptor agonists in kindled amygdala of rats , 1996, Neuroscience Letters.

[14]  S. Nakanishi,et al.  Distributions of the mRNAs for L‐2‐amino‐4‐phosphonobutyrate‐sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain , 1995, The Journal of comparative neurology.

[15]  A. J. Carter,et al.  Metabotropic glutamate receptor subtypes differentially influence neuronal recovery from in vitro hypoxia/hypoglycemia in rat hippocampal slices , 1995, Neuroscience.

[16]  D. Manahan‐Vaughan,et al.  Regional and developmental profile of modulation of hippocampal synaptic transmission and LTP by AP4-sensitive mGluRs in vivo , 1995, Neuropharmacology.

[17]  Shigetada Nakanishi,et al.  Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity , 1994, Neuron.

[18]  E. Mulvihill,et al.  Changes in Metabotropic Glutamate Receptor mRNA Levels Following Global Ischemia: Increase of a Putative Presynaptic Subtype (mGluR4) in Highly Vulnerable Rat Brain Areas , 1994, Journal of neurochemistry.

[19]  N. Diemer,et al.  Changes in mRNA for metabotropic glutamate receptors after transient cerebral ischaemia. , 1994, Neuroreport.

[20]  G. Lombardi,et al.  Pharmacological characterization of the metabotropic glutamate receptor inhibiting d‐[3H]‐aspartate output in rat striatum , 1993, British journal of pharmacology.

[21]  A. Villringer,et al.  Global forebrain ischaemia in the rat: controlled reduction of cerebral blood flow by hypobaric hypotension and two-vessel occlusion. , 1993, Neurological research.

[22]  D. Schoepp.  The biochemical pharmacology of metabotropic glutamate receptors. , 1993, Biochemical Society transactions.

[23]  P. Suzdak,et al.  L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type iv metabotropic glutamate receptor which is negatively coupled to adenylate cyclase , 1992 .

[24]  S. Nakanishi.  Molecular diversity of glutamate receptors and implications for brain function. , 1992, Science.

[25]  R. Gwinn,et al.  Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87 , 1992, Brain Research.

[26]  S. Nakanishi,et al.  A family of metabotropic glutamate receptors , 1992, Neuron.

[27]  F. Marcoux,et al.  Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartic acid antagonists. , 1989, Journal of medicinal chemistry.

[28]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.